Inventor · disambiguated record
Andrew Denker
Also filed as: DENKER ANDREW · DENKER ANDREW E · DENKER ANDREW EVAN
7 granted patents·5 pending applications·13 citations·filing 2002–2024
77Inventor score
Files withALEXION PHARMA INC4MERCK SHARP & DOHME LLC3EISAI R&D MAN CO LTD1MEINKE PETER T1MERCK & CO INC1
Top patents by PatentIndex Score
12 records- 0190US10751412B2Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancerMERCK SHARP & DOHME·Filed 2016·Granted Aug 25, 2020·6 cites·28 claims
- 0287US11547705B2Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancerMERCK SHARP & DOHME LLC·Filed 2016·Granted Jan 10, 2023·4 cites·32 claims
- 0377US2025000853A1Combination of a pd-1 antagonist and a vegf-r/fgfr/ret tyrosine kinase inhibitor for treating cancerEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0471US12083112B2Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancerMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 10, 2024·0 cites·21 claims
- 0563US11918648B2Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancerMERCK SHARP & DOHME LLC·Filed 2020·Granted Mar 5, 2024·0 cites·9 claims
- 0662US8338458B2Method of treatment using fused aromatic compounds having anti-diabetic activityMEINKE PETER T·Filed 2008·Granted Dec 25, 2012·3 cites·14 claims
- 0752US2005261250A1Compositions and methods for inhibiting bone resorptionMERCK & CO INC·Filed 2004·Application pending·0 cites
- 0851US2023043576A1Methods of treating pregnancy-associated atypical hemolytic uremic syndrome using an anti-c5 antibodyALEXION PHARMA INC·Filed 2020·Application pending·0 cites
- 0945US2021388070A1Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditionsALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1042US12460012B2Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patientsALEXION PHARMA INC·Filed 2019·Granted Nov 4, 2025·0 cites·15 claims
- 1140US11224637B2Methods for treating hypophosphatasia (HPP) in adults and adolescentsALEXION PHARMA INC·Filed 2018·Granted Jan 18, 2022·0 cites·20 claims
- 1235US2003139378A1Liquid bisphosphonate formulations for bone disordersFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Denker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →